Marc S. Krug

723 total citations
25 papers, 614 citations indexed

About

Marc S. Krug is a scholar working on Molecular Biology, Sensory Systems and Otorhinolaryngology. According to data from OpenAlex, Marc S. Krug has authored 25 papers receiving a total of 614 indexed citations (citations by other indexed papers that have themselves been cited), including 13 papers in Molecular Biology, 6 papers in Sensory Systems and 5 papers in Otorhinolaryngology. Recurrent topics in Marc S. Krug's work include RNA and protein synthesis mechanisms (8 papers), Hearing, Cochlea, Tinnitus, Genetics (5 papers) and Ear Surgery and Otitis Media (5 papers). Marc S. Krug is often cited by papers focused on RNA and protein synthesis mechanisms (8 papers), Hearing, Cochlea, Tinnitus, Genetics (5 papers) and Ear Surgery and Otitis Media (5 papers). Marc S. Krug collaborates with scholars based in United States, South Korea and Japan. Marc S. Krug's co-authors include Shelby L. Berger, Richard E. Manrow, William H. Eschenfeldt, Olke C. Uhlenbeck, T.J. Yoo, Joel Bernstein, Pieter L. De Haseth, Tatsuya Fujiyoshi, Jerome M. Seyer and Yoshiro Yazawa and has published in prestigious journals such as Proceedings of the National Academy of Sciences, Journal of Biological Chemistry and Biochemistry.

In The Last Decade

Marc S. Krug

25 papers receiving 588 citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
Marc S. Krug United States 13 316 98 76 71 71 25 614
Ángela Ballesteros United States 16 338 1.1× 90 0.9× 587 7.7× 15 0.2× 166 2.3× 26 1.0k
Zhanying Hu China 18 232 0.7× 15 0.2× 83 1.1× 28 0.4× 6 0.1× 28 794
Jason Treadaway United States 7 290 0.9× 38 0.4× 146 1.9× 83 1.2× 52 0.7× 8 914
Barbara J. Schmeckpeper United States 12 478 1.5× 41 0.4× 217 2.9× 29 0.4× 15 0.2× 15 845
Guillermo S. Romano Ibarra United States 8 432 1.4× 135 1.4× 104 1.4× 68 1.0× 3 0.0× 10 702
R. Thomas Taggart United States 12 508 1.6× 9 0.1× 94 1.2× 44 0.6× 29 0.4× 21 791
Genaro Patiño‐López Mexico 17 419 1.3× 45 0.5× 260 3.4× 6 0.1× 9 0.1× 48 935
Lata Balakrishnan United States 20 1.0k 3.2× 9 0.1× 36 0.5× 30 0.4× 19 0.3× 52 1.2k
E. P. C. Tock Singapore 10 532 1.7× 12 0.1× 97 1.3× 10 0.1× 9 0.1× 23 902
Angelica Medina-Selby United States 13 293 0.9× 25 0.3× 109 1.4× 54 0.8× 5 0.1× 16 719

Countries citing papers authored by Marc S. Krug

Since Specialization
Citations

This map shows the geographic impact of Marc S. Krug's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Marc S. Krug with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Marc S. Krug more than expected).

Fields of papers citing papers by Marc S. Krug

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Marc S. Krug. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Marc S. Krug. The network helps show where Marc S. Krug may publish in the future.

Co-authorship network of co-authors of Marc S. Krug

This figure shows the co-authorship network connecting the top 25 collaborators of Marc S. Krug. A scholar is included among the top collaborators of Marc S. Krug based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Marc S. Krug. Marc S. Krug is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

20 of 20 papers shown
1.
Suzuki, Mikio, Marc S. Krug, Y. Yazawa, et al.. (2003). Antibodies against inner ear proteins in the sera of patients with inner ear diseases. International Congress Series. 1240. 1163–1167. 1 indexed citations
2.
Matsuoka, Hiroshi, Kyung‐Mi Lee, Soon Seog Kwon, et al.. (2000). Proto-Oncogene Raf-1 as an Autoantigen in Meniere's Disease. Annals of Otology Rhinology & Laryngology. 109(12). 1093–1098. 13 indexed citations
3.
Lee, Kyung‐Mi, et al.. (1998). House dust mite–induced sensitivity in mice. Journal of Allergy and Clinical Immunology. 101(1). 51–59. 13 indexed citations
4.
Chiang, Huey‐Jenn, et al.. (1997). TCRV and TCRJ gene usage in MBP responding T cells from (B10.PL×PL/J)F1 mice is biased towards that of B10.PL mice. Journal of Neuroimmunology. 80(1-2). 13–22. 1 indexed citations
5.
6.
Suzuki, Mikio, et al.. (1997). The Cochlear Protein Antigens 28 kd and 30 kd, and Their Antibodies in Ménière's Diseasea. Annals of the New York Academy of Sciences. 830(1). 211–220. 2 indexed citations
7.
Yoo, T.J., et al.. (1997). Molecular Basis of Type II Collagen Autoimmune Ear Diseasesa. Annals of the New York Academy of Sciences. 830(1). 221–235. 1 indexed citations
8.
Suzuki, Mikio, Marc S. Krug, Kuang‐Chuan Cheng, et al.. (1997). Antibodies against Inner-Ear Proteins in the Sera of Patients with Inner-Ear Diseases. ORL. 59(1). 10–17. 30 indexed citations
9.
Marion, Tony N., Kuniaki Terato, Jacob Aelion, et al.. (1996). Variable-Region Gene Family Usage for Type II Collagen Autoantibodies in Arthritis-Susceptible DBA/1 Mice. Clinical Immunology and Immunopathology. 78(3). 263–275. 3 indexed citations
10.
Yoo, T.J., Huey‐Jenn Chiang, Kai Wang, et al.. (1994). Epitope Specificity and T Cell Receptor Usage in Type II Collagen Induced Autoimmune Ear Disease. Cellular Immunology. 157(1). 249–262. 13 indexed citations
11.
Manrow, Richard E., Alvaro Leone, Marc S. Krug, William H. Eschenfeldt, & Shelby L. Berger. (1992). The human prothymosin α gene family contains several processed pseudogenes lacking deleterious lesions. Genomics. 13(2). 319–331. 18 indexed citations
12.
Krug, Marc S. & Shelby L. Berger. (1991). Reverse transcriptase from human immunodeficiency virus: a single template-primer binding site serves two physically separable catalytic functions. Biochemistry. 30(44). 10614–10623. 21 indexed citations
13.
Leone, Alvaro, Marc S. Krug, Richard E. Manrow, & Shelby L. Berger. (1989). Mapping introns by exon excision. Analytical Biochemistry. 183(1). 64–73. 1 indexed citations
14.
Eschenfeldt, William H., Richard E. Manrow, Marc S. Krug, & Shelby L. Berger. (1989). Isolation and partial sequencing of the human prothymosin α gene family. Journal of Biological Chemistry. 264(13). 7546–7555. 80 indexed citations
15.
Krug, Marc S. & Shelby L. Berger. (1989). Ribonuclease H activities associated with viral reverse transcriptases are endonucleases.. Proceedings of the National Academy of Sciences. 86(10). 3539–3543. 66 indexed citations
16.
Krug, Marc S. & Shelby L. Berger. (1987). [33] First-strand cDNA synthesis primed with oligo(dT). Methods in enzymology on CD-ROM/Methods in enzymology. 152. 316–325. 198 indexed citations
17.
Krug, Marc S. & Shelby L. Berger. (1987). [26] Determination of the molar concentration of messenger RNA. Methods in enzymology on CD-ROM/Methods in enzymology. 152. 262–266. 2 indexed citations
18.
Krug, Marc S. & Shelby L. Berger. (1986). A micromethod for measuring the molar concentration of polyadenylated RNA in the presence of ribosomal RNA. Analytical Biochemistry. 153(2). 315–323. 12 indexed citations
19.
Carey, Jannette, Vicki Cameron, Marc S. Krug, Pieter L. De Haseth, & Olke C. Uhlenbeck. (1984). Failure of translational repression in the phage f2 op3 mutant is not due to an altered coat protein-RNA interaction.. Journal of Biological Chemistry. 259(1). 20–22. 5 indexed citations
20.
Krug, Marc S. & Olke C. Uhlenbeck. (1982). Reversal of T4 RNA ligase. Biochemistry. 21(8). 1858–1864. 18 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Rankless by CCL
2026